ALEMBIC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and eighty-nine approved drugs.
There are nine tentative approvals on ALEMBIC drugs.
Summary for ALEMBIC
| US Patents: | 0 |
| Tradenames: | 147 |
| Ingredients: | 146 |
| NDAs: | 189 |
| Patent Litigation for ALEMBIC: | See patent lawsuits for ALEMBIC |
| PTAB Cases with ALEMBIC as petitioner: | See PTAB cases with ALEMBIC as petitioner |
Drugs and US Patents for ALEMBIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 211821-002 | Oct 1, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic | ADAPALENE | adapalene | GEL;TOPICAL | 213508-001 | Jun 18, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204518-007 | Jan 2, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic | AMLODIPINE BESYLATE AND VALSARTAN | amlodipine besylate; valsartan | TABLET;ORAL | 202713-002 | Apr 3, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
